Japan hosts Gavi COVAX AMC summit virtual event securing $2.4 B
Vaccines | News | 0 Comment | 07 Jun, 2021
World leaders joined forces on 2 June at the “One World Protected” - Gavi COVAX Advance Market Commitme...Read more
Gavi welcomes U.S. strategy for Global Vaccine Sharing
Vaccines | News | 0 Comment | 07 Jun, 2021
Gavi, the Vaccine Alliance, welcomes the announcement by the United States Government of its strategy for glob...Read more
Bahrain to establish production of Sputnik V vaccine
Vaccines | News | 0 Comment | 04 Jun, 2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Bahrain’s Mumtalakat Holding Comp...Read more
Korea's IVI to develop adaptive Ph 1b/2a schistosomiasis vaccine trial
Vaccines | News | 0 Comment | 03 Jun, 2021
The International Vaccine Institute (IVI) in South Korea has announced that the Bill & Melinda Gates Foundation has ...Read more
Biological E partners with Canadian firm to manufacture mRNA vaccines in India
Vaccines | News | 0 Comment | 02 Jun, 2021
Canadian firm Providence Therapeutics Holdings Inc. and India's Biological E have announced the execution of a term shee...Read more
WHO approves China's Sinovac COVID-19 vaccine for emergency use
Vaccines | News | 0 Comment | 02 Jun, 2021
The World Health Organisation (WHO) has validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving ...Read more
Australia connects metabolic hormone leptin with vaccine response
Vaccines | News | 0 Comment | 28 May, 2021
Reduced levels of a metabolic hormone known as leptin, largely produced by fat tissue, is linked to poor vaccine antibod...Read more
CEPI injects additional funding of $173.4 M into Korean firm SK bioscience's vaccine project
Vaccines | News | 0 Comment | 28 May, 2021
CEPI, the Coalition for Epidemic Preparedness Innovations, and SK bioscience have announced an expanded partnership to d...Read more
Singapore approves new storage condition for Pfizer COVID-19 vaccine
Vaccines | News | 0 Comment | 26 May, 2021
The Health Sciences Authority (HSA) in Singapore has approved the new storage condition for the Pfizer-BioNTech COVID-19...Read more
CanSino receives GMP certificate for Convidecia™, COVID-19 vaccine
Vaccines | News | 0 Comment | 25 May, 2021
CanSino Biologics Inc has announced that its recombinant novel coronavirus vaccine, (Adenovirus Type 5 Vector) (‘A...Read more
South Korea explores expansion of COVID-19 vaccine activities
Vaccines | News | 0 Comment | 25 May, 2021
Novavax, Inc., a US-based biotechnology company developing next-generation vaccines for serious infectious diseases, has...Read more
RDIF, Panacea Biotec launch production of Sputnik V in India
Vaccines | News | 0 Comment | 24 May, 2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading v...Read more
Research confirms trusted sources key to vaccination program success
Vaccines | Opinion | 2 Comment | 24 May, 2021
Last month was World Immunization Week and never has it been a more pertinent milestone. It has been 13 months since the...Read more
Singapore extends use of Pfizer-BioNTech COVID-19 vaccine to adolescents
Vaccines | News | 0 Comment | 19 May, 2021
The Health Sciences Authority (HSA) at Singapore has extended the authorisation of Pfizer-BioNTech COVID-19 vaccine for ...Read more
Australia to soon roll-out single-dose COVID-19 vaccine
Vaccines | News | 0 Comment | 17 May, 2021
A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials....Read more
Moderna to supply 25 M vaccine doses to Australia
Vaccines | News | 0 Comment | 14 May, 2021
Moderna, Inc., has announced a new supply agreement with the government of Australia for 25 million doses. Thi...Read more
Fosun, BioNTech invest $200 M to manufacture COVID-19 vaccine in China
Vaccines | News | 0 Comment | 12 May, 2021
Shanghai Fosun Pharma has signed a Joint Venture with BioNTech to manufacture mRNA vaccine in China. The JV will ha...Read more
EU inks the third contract with BioNTech/Pfizer securing 1.8 billion doses
Vaccines | News | 0 Comment | 11 May, 2021
The European Commission has approved a contract for 1.8 billion doses of the BioNTech/Pfizer vaccine. The contract cove...Read more